Abstract ID | Abstract Title | Presenting Author |
98 | A Need For Optimisation Of Therpeutic Plasmaphersis In Children- An Analysis Of Five Cases With Reference to Guiidelines from the American Society for Apheresis | Kalpana Velaskar |
95 | The Essential Paediatric Autologous Peripheral Blood Stem Cell Collections -Value Additions And Lessons Learned | Kalpana Velaskar |
77 | A Model for Creating Stem Cell Transplantation (SCT) Programs in low- and middle-income countries (LMIC): Experience form 11 SCT Programs | Amey Chandrakant Panchal |
44 | Global Physical Health of Auto-HCT Survivors at Day+100 Post Hematopoietic Cell Transplantation (HCT) Lags FACT-BMT Health-Related Quality of Life Subscales Compared to Allo-HCT Survivors. | Ritika Sharma |
35 | Effect of controlled loss of 350 ml blood from human body on electrolytes and albumin levels – An observational study done in whole blood donors at a regional blood centre | Shanavas A |
17 | Implementation of Quality Management System (QMS) Improves Peripheral Stem Cell Collection Service in an Indian Center | Rizwan Javed |
15 | Reversible coagulopathy during infusion of cryopreserved stem cell product – a case report | Anju Radhakrishna Kurup |
9 | Factors Impacting Return to Work/School among Hematopoietic Cell Transplantation Survivors | Andrew Pardeep |
91 | Outcomes of allogeneic hsct for aplastic anemia – a single centre experience from northern india. | Sanjeev |
66 | Hematopoetic stem cell transplantation in bihar: 49 not out. | Santosh Kumar |
65 | Allogeneic Hematopoietic Stem Cell Transplant FOR Aplastic Anemia at PARAS HMRI Hospital, Patna: Our experience. | Santosh Kumar |
26 | Augmented Conditioning for Successful Second Haplo Identical Transplant For Very Severe Aplastic Anemia Triggering Prolonged Secondary HLH And Ganciclovir Resistant Refractory CMV Reactivation. | Vemulapally Lavanya |
21 | Haploidentical HSCT with post-transplant cyclophosphamide for children with Fanconi anemia with and without anti-thymocyte globulin: a comparison study from a tertiary care center in India | Kavitha Ganesan |
99 | Fludarabine/Treosulfan/TBI (Flu/Treo/TBI) as a Conditioning regimen for T cell replete Haploidentical transplant (Haplo- HSCT) | Punit Jain |
57 | Inferior outcomes with Melphalan based conditioning compared to Busulfan with Fludarabine in children undergoing HSCT | Suresh R D |
51 | Matched sibling donor transplant in aplastic anemia with post transplant cyclophosphamide – initial experience!! | Devyani Surange |
50 | A case of haploidentical stem cell transplant with primary engraftment failure – rescued with 2nd haploidentical tranplant | Devyani Surange |
16 | Outcomes of upfront haploidentical transplant using 4gy tbi and post transplant cyclophosphamide in pediatric severe aplastic anemia | Rohit Kapoor |
88 | A study to assess the effectiveness of structured teaching programme on knowledge regarding gvhd among staff nurses. | Shankar Shivaji Varekar |
49 | Steroid Refractory Acute Graft-Versus-Host-Disease (GVHD) In A Matched-Unrelated-Donor (MUD) Transplant: What Next? | Lorie Gandhi |
48 | Management Of Acute Grade 4 Gut Graft-Versus-Host-Disease (GVHD): Challenging Yet Gratifying! | Lorie Gandhi |
24 | Retrospective Study To Assess The Prevalence Of Acute/Early Complications In Post HSCT Patients | Anjusha K |
5 | Hypoxia-primed tissue-specific mesenchymal stromal cells augment immunomodulatory potential to mitigate acute graft-versus-host-disease | Mohini Mendiratta |
105 | Long term outcomes of allogeneic hematopoietic stem cell transplantation in patients with adreno Leukodystrophies | Fouzia.N.A |
104 | Long-term outcome of haematopoietic stem cell transplantation in osteopetrosis – A single centre experience | Fouzia.N.A |
70 | The slow bleeder – a retrospective analysis of the time taken to reduce iron overload post transplantation in children with thalassemia major | Kavitha Ganesan |
33 | Rescuing the Alveolar Macrophage Function with Allogeneic Hematopoietic Stem Cell Transplant in Hereditary Pulmonary Alveolar Proteinosis | Varsha Mishra |
3 | Evaluation of Transient Elastography, Hepatic Iron Concentration by MRI T2* Liver, Serum Liver Fibrosis Indexes versus Liver Biopsy in Thalassemia Major patients who are candidates for Haematopoietic Stem cell transplant, A Comparative Pilot Study | Mona Vijayaran |
93 | Study of Clinical Profile and Complications of Autologous Stem Cell Transplantation- A Single Institutional Experience | Tarjina Begum |
89 | Role of Granulocyte transfusions in Hematopoetic stem cell transplantation: Experience from a tertiary care hospital in North India | Sanjeev |
86 | Carbapenem-Resistant Organism (CRO) in Haploidentical transplant (Haplo-HSCT): The Elephant in the Room. | Laxman Jessani |
82 | Study of Clinical Profile and Complications of Autologous Stem Cell Transplantation- A Single Institutional Experience | Tarjina Begum |
67 | BK Virus Haemorrhagic Cystitis in Alternate Donor Stem Cell Transplants using Post- Transplant Cyclophosphamide Based Regimens – Does The Type Of Mesna Prophylaxis Matter? | Sohini Chakraborty |
40 | Granulocyte transfusion as an adjunct to antimicrobial treatment in high-risk febrile neutropenia: A phase 2, non-randomised controlled trial | Samrudhi Joshi |
29 | Tuberculosis in allogenic stem cell transplant recipients a case series | Neal Antonio Joseph |
83 | “25 Years of Saving Lives: Celebrating the Success of Army Hospital’s Bone Marrow Transplant Center” | Kundan Mishra |
80 | Isolated Urinary Bladder Post-transplant Lymphoproliferative Disorder in a Haploidentical Hematopoietic Stem Cell Transplant Recipient | Revanth Boddu |
76 | Late Isolated Extramedullary Relapse With Complete Chimerism In Adverse Risk AML: Two Cases: Treatment Outcome | Bilal Kazi |
74 | Haploidentical HSCT in Relapsed Pediatric BPDCN using GIAC strategy: The First Case at IRCH, AIIMS | Kanu Priya Bhatia |
72 | Uncontrolled Leukaemia is the Main Cause of Rejection in Allogeneic Haematopoietic Stem Cell Transplantations | Ashish Dhoot |
71 | Transverse Myelitis in a child with AML , post Haploidentical Hematopoietic Stem Cell Transplantation | Gourav Bain |
42 | Navigating the Complexities of Treating Relapsed Mixed Phenotypic Leukemia: A Clinical Case Discussion | Gala Deep Ajay |
39 | Targeted antibody-based therapies induce MRD-negative remission in all patients with Relapsed and Refractory Paediatric Acute Lymphoblastic Leukemia | Sanaa Khan |
27 | Comparative Analysis of TCRαβ depleted Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) in Paediatric And Adult Patients :Single Center Experience | Naveed Tamboli |
22 | B – Cell Prolymphocytic Leukemia: Clinical Profile and Treatment Outcomes at a Tertiary Cancer Centre in South India | Akansha Choudhary |
19 | A Case Report on Primary Refractory Acute Myeloblastic Leukemia with Tp53 Mutation and Myeloid Sarcoma in a Young Adult | A.R.Jaswanthini |
114 | Autologous Stem Cell Transplant for Multiple Myeloma: 13 years’ Experience from a Single Tertiary Care Centre in India | Manasi Gupta |
112 | Outcome Of Autologous Stem Cell Transplantation In Relapsed/ Refractory Lymphomas – A Single Center Experience | Chaitanya G B |
111 | Real World Data on Autologous Stem Cell Transplant in Amyloidosis : A Case Series from a Tertiary Cancer Care Centre in India | Sandeep Abhijit Pattnaik |
108 | Demographics, Toxicities and Outcomes of Hematopoietic Stem Cell Transplant (HSCT) for Hematolymphoid Malignancies in a New Transplant Centre at Homi Bhabha Cancer Hospital (HBCH), Tata Memorial Centre (TMC), Varanasi. | Kunal Goyal |
107 | Mimicking the great mimic: Familial HLH masquerading as Hodgkin’s disease | Sanal Fernandes |
96 | Outcomes of stem cell transplantation for lymphoma : A single center experience from north india | Sanjeev . |
94 | Autologous stem cell transplantation for multiple myeloma – a single center experience from north india | Sanjeev |
73 | Role of ASCT in Primary Amyloidosis: Outcomes From A Tertiary Care Cancer Center Of India | Kanu Priya Bhatia |
63 | The Impact Of Multiple Myeloma Induction Therapy On Stem Cell Mobilization And Collection. | Harshal Mamlekar |
43 | MEL 200 vs. MEL 140: Real World Outcomes Of Multiple Myeloma Post Autologous Stem Cell Transplant – Data From A Tertiary Care Single Institute In East India. | Arjin Philips |
38 | Outcomes of brentuximab in relapsed or refractory hodgkin lymphoma: early experience from patient access programme in india | Jyothi Goutham Kumar |
37 | Primary Bone Lymphoma: Case Series from a tertiary cancer care centre ” | Akansha Choudhary |
23 | Autologous Stem Cell Transplantation for Multiple Myeloma: Single Centre Experience from PARAS HMRI Hospital Patna, Bihar. | Santosh Kumar |
18 | A Case Report on Composite Lymphoma with Repeated Histologic Transformation and Relapse after Autologous Stem Cell Transplant | A.R.Jaswanthini |
13 | Role of the Gut Microbiome in Autologous Hematopoietic Cell Transplantation | Shaweta Kaundal |
10 | Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-centre experience | Chirag Trivedi |
8 | Prophylactic romiplostim use in ASCT in multiple myeloma is effective and cost efficient | Vadlamani Surya Prakash |
100 | Haploidentical Stem Cell Transplantation using Post-transplant Cyclophosphamide in pediatric patients: The AIIMS Experience | Sanal Fernandes |
87 | Tacrolimus induced type iv renal tubular acidosis in a pediatric hsct patient | Santanu Sen |
85 | Cutaneous manifestations post paediatric allogenic Hematopoietic Stem Cell Transplant: Our centre experience | Juhi Mehrotra |
79 | Successful Allogenic Hematopoietic Stem Cell transplant in a Paediatric HIV positive recipient | Juhi Mehrotra |
78 | Fludarabine/Busulfan versus Thiotepa/Fludarabine/Cyclophosphamide/Total Body Irradiation Based Conditioning in Haploidentical Donor Hematopoietic Stem Cell Transplant for Sickle Cell Disease – Which One to Choose? | Minakshi Bansal Vohra |
64 | Optimising outcomes for children undergoing haploidentical HSCT for thalassemia major with hla antibodies | Suresh R D |
61 | Allogeneic Hematopoietic Stem Cell Transplantation For Primary Immunodeficiency Disorders : a Single Center Experience | Gayathri S |
60 | Clinical Profile And Outcome Of Allogeneic Hematopoietic Stem Cell Transplantation In Children with Thalassemia Major : Last 5 years Experience from tertiary care center in India | Gayathri S |
56 | Triple prophylaxis with continuous MESNA and N Acetylcysteine infusion protocol and oral ciprofloxacin as a low-cost and effective intervention to prevent BK virus haemorrhagic cystitis in children undergoing haploidentical HSCT with PTCy | Navyasri Yenigalla |
53 | Chronic graft versus host disease (GVHD) with mixed chimerism post T cell repleted haploidentical hematopoietic stem cell transplant (HSCT) in a child with leucocyte adhesion defect type 1. | Vipin Khandelwal |
47 | bedside insertion of central venous catheters in children undergoing HSCT – challenges and solutions | Haritha.S |
46 | Treosulfan induced cartilage damage in children post hematopoietic stem cell transplantation – case series | Deepika.L |
32 | Allogenic Hematopoietic Stem Cell Transplantation In Lysosomal Storage Disorders: A Single Centre Experience In India | Lakshmi T |
31 | Outcome of Haploidentical HSCT in Pediatric Aplastic Anemia: 1 year experience | Santanu Sen |
30 | Autoimmune cytopenia’s post hematopoietic stem cell transplantion in children. | Manojit Chakraborty |
20 | Is there a role for high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell transplantation (AHSCT) in high-risk neuroblastoma in resource-limited settings? | Kritthivasan Venkatakrishnan |
12 | Improved thalassemia-free survival after optimizing the conditioning regimen in T-replete haploidentical hematopoietic stem cell transplantation | Venkateswaran V S |
11 | Miraculous recovery with metronomic therapy in a patient with Acute lymphoblastic leukemia (ALL) who had relapse post T cell repleted Haploidentical Hematopoietic stem cell transplant(HSCT). | Vipin Khandelwal |
7 | Successful treatment of high cmv viral load in a child with primary graft failure post t cell repleted haploidentical hematopoietic stem cell transplant (HSCT) for sickle cell disease. | Vipin Khandelwal |
4 | Successful desensitization in a patient with very high MFI donor specific antibodies persisting after pretransplant immunosuppression using IVIG and plasma exchange. | Rohit Kapoor |
75 | Mobilization of Backup Autologous Peripheral Stem Cells in Pediatric Thalassemia Patients: A Single Center Experience | Pooja Prakash Mallya |
Quick Links
Reach Us
Indian Society for Blood and Marrow Transplantation
Dept. of Hematology,
Christian Medical College,
Vellore - 632004, India.
Phone: 0416 2283529
Email: office@isbmt.org
Website: www.isbmt.org